Dr. Gong Huiping

What they personally lead.

Training and recognition

Established and expanded the newborn screening program at Children's Hospital of Fudan University, one of the largest and most advanced in China, screening hundreds of thousands of newborns annually using tandem mass spectrometry and genetic confirmation testing; led research that identified the mutation spectrum of metabolic disorders in the Chinese population, informing targeted screening panel design; developed clinical management pathways for phenylketonuria, methylmalonic acidemia, and other common inborn errors of metabolism that have improved long-term neurodevelopmental outcomes in treated patients; contributed to national newborn screening policy and quality assurance standards; published in Journal of Inherited Metabolic Disease, Molecular Genetics and Metabolism, and Clinical Chemistry

What to expect

Dr. Gong is the recommended specialist for newborns or infants with abnormal newborn screening results, suspected metabolic crises, or confirmed inborn errors of metabolism requiring long-term dietary and medical management. Families seeking second opinions on metabolic disease diagnoses or treatment optimization will find his program at Children's Hospital of Fudan University among the most experienced in China. The hospital's international department can assist with appointment scheduling and interpretation services.

Check the public record

Look up publications, citations, and academic profile on independent platforms before reaching out.

Results are automated searches and may include other individuals with similar names.